Cancer is one of the leading causes of death in the world while the long-term prognosis is still unfavorable, despite the enormous efforts in the search for effective anti-cancer drugs. We think that the obstacle for creating of effective anti-cancer drugs could be existing idea that the basis of cancer is caused by the damage of the genetic apparatus of the cell. In this paper, we present the pathogenesis of cancer which is based on the formation of the special sustainable pathophysiological state of the organism what we call the state of “cancer reparative trap”. The essence of this pathophysiological state of the organism is in the reparative orientation of the immune system of cancer patients, when constant tissue repair is accompanied by systemic suppression of the anti-tumor immunity. Specifically, during the long-term exposure to carcinogens (exogenous and/or endogenous), the continuous tissue damage occurs which induces permanent stimulation of cell proliferation (imbalanced Th1 < Th2 lymphocytes, M1 < M2 macrophages, inflammation, angiogenesis, etc.) in order to repair the tissues damaged. At the same time, tissue repair is necessarily accompanied by the suppression of anti-tumor immunity (increase in T-regulatory cells, imbalanced Th1 < Th2 lymphocytes, M1 < M2 macrophages et al. ), which creates the necessary conditions for the survival of the malignantly transformed cells, formed by the action of carcinogens. The determining role of the imbalance in the autonomous nervous system (simpathetic/hypersympathetic dominance) in the development, maintenance and generalization of the cancer process has been shown. The explanation of a number of phenomena has been presented: the cell resistance to chemotherapy, and the phenomenon of cancer cell dormancy. The promising approaches for the cancer management in clinical practice have been proposed.
Weinberg, R.A. (2006) The Biologу of Cancer. Garland Science, New York, 796 p.
Kushlinskii, N.E. and Nemtsova, M.V. (2014) Molecular Biological Characteristics of Cancer. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, 1-2, 5-15.
Bizzarri, M. and Cucina, A. (2014) Tumor and the Microenvironment: A Chance to Reframe the Paradigm of Carcinogenesis? BioMed Research International, 2014, Article ID: 934038. http://dx.doi.org/10.1155/2014/934038
Herbst, R.S., Bajorin, D.F., Bleiberg, H., Blum, D., Hao, D., Johnson, B.E., et al. (2006) Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report from the American Society of Clinical Oncology. Journal of Clinical Oncology, 24, 190-205. http://dx.doi.org/10.1200/JCO.2005.04.8678
Stewart, B.W. and Wild, C.P. (2014) World Cancer Report 2014. IARC Nonserial Publication (WHO), 630 p.
Pitot, H.C. and Dragan, Y.P. (1991) Facts and Theories Concerning the Mechanisms of Carcinogenesis. The FASEB Journal, 5, 2280-2286.
Halazonetis, T.D., Gorgoulis, V.G. and Bartek, J. (2008) An Oncogene-Induced DNA Damage Model for Cancer Development. Science, 319, 1352-1355. http://dx.doi.org/10.1126/science.1140735
Collisson, E.A., Cho, R.J. and Gray, J.W. (2012) What Are We Learning from the Cancer Genome? Nature Reviews Clinical Oncology, 9, 621-630. http://dx.doi.org/10.1038/nrclinonc.2012.159
Das, S.K., Menezes, M.E., Bhatia, S., Wang, X.Y., Emdad, L., Sarkar, D. and Fisher, P.B. (2015) Gene Therapies for Cancer: Strategies, Challenges and Successes. Journal of Cellular Physiology, 230, 259-271. http://dx.doi.org/10.1002/jcp.24791
Lu, H., Ouyang, W. and Huang, C. (2006) Inflammation, a Key Event in Cancer Development. Molecular Cancer Research, 4, 221-233. http://dx.doi.org/10.1158/1541-7786.MCR-05-0261
Prendergast, G.C. and Jaffee, E.M. (2007) Cancer Immunologists and Cancer Biologists: Why We Didn’t Talk Then but Need to Now. Cancer Research, 67, 3500-3504. http://dx.doi.org/10.1158/0008-5472.CAN-06-4626
Poggi, A. and Zocchi, M.R. (2006) Mechanisms of Tumor Escape: Role of Tumor Microenvironment in Inducing Apoptosis of Cytolytic Effector Cells. Archivum Immunologiae et Therapiae Experimentalis (Warszawa), 54, 323-333. http://dx.doi.org/10.1007/s00005-006-0038-7
Burkholder, B., Huang, R.Y., Burgess, R., Luo, S., Jones, V.S., Zhang, W., et al. (2014) Tumor-Induced Perturbations of Cytokines and Immune Cell Networks. Biochimica et Biophysica Acta, 1845, 182-201. http://dx.doi.org/10.1016/j.bbcan.2014.01.004
Vona-Davis, L. and Rose, D.P. (2007) Adipokines as Endocrine, Paracrine, and Autocrine Factors in Breast Cancer Risk and Progression. Endocrine Related Cancer, 14, 189-206. http://dx.doi.org/10.1677/ERC-06-0068
Baccelli, I. and Trumpp, A. (2012) The Evolving Concept of Cancer and Metastasis Stem Cells. Journal of Cell Biology, 198, 281-293. http://dx.doi.org/10.1083/jcb.201202014
Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A.P. and Bellet, D. (2007) Molecular Circuits Shared by Placental and Cancer Cells, and Their Implications in the Proliferative, Invasive and Migratory Capacities of Trophoblasts. Human Reproduction Update, 13,121-141. http://dx.doi.org/10.1093/humupd/dml048
Reuter, S., Gupta, S.C., Chaturvedi, M.M. and Aggarwal, B.B. (2010) Oxidative Stress, Inflammation, and Cancer: How Are They Linked? Free Radical Biology and Medicine, 49, 1603-1616. http://dx.doi.org/10.1016/j.freeradbiomed.2010.09.006
Toyokuni, S., Okamoto, K., Yodoi, J. and Hiai, H. (1995) Persistent Oxidative Stress in Cancer. FEBS Letters, 358, 1-3. http://dx.doi.org/10.1016/0014-5793(94)01368-B
Crawford, S. (2014) Anti-Inflammatory/Antioxidant Use in Long-Term Maintenance Cancer Therapy: A New Therapeutic Approach to Disease Progression and Recurrence. Therapeutic Advances in Medical Oncology, 6, 52-68. http://dx.doi.org/10.1177/1758834014521111
Ng, S. and Galipeau, J. (2015) Concise Review: Engineering the Fusion of Cytokines for the Modulation of Immune Cellular Responses in Cancer and Autoimmune Disorders. Stem Cells Translational Medicine, 4, 66-73. http://dx.doi.org/10.5966/sctm.2014-0145
Ascierto, P.A., Addeo, R., Carteni, G., Daniele, B., De Laurentis, M., Ianniello, G., et al. (2014) The Role of Immunotherapy in Solid Tumors: Report from the Campania Society of Oncology Immunotherapy (SCITO) Meeting, Naples 2014. Journal of Translational Medicine, 12, 291. http://www.translational-medicine.com/content/12/1/291 http://dx.doi.org/10.1186/s12967-014-0291-1
Kenderian, S.S., Ruella, M., Gill, S. and Kalos, M. (2014) Chimeric Antigen Receptor T-Cell Therapy to Target Hematologic Malignancies. Cancer Research, 74, 6383-6389. http://dx.doi.org/10.1158/0008-5472.CAN-14-1530
Westwood, J.A. and Kershaw, M.H. (2010) Genetic Redirection of T Cells for Cancer Therapy. Journal of Leukocyte Biology, 87, 791-803. http://dx.doi.org/10.1189/jlb.1209824
Pol, J., Bloy, N., Obrist, F., Eggermont, A., Galon, J., Hervé Fridman, W., et al. (2014) Trial Watch: DNA Vaccines for Cancer Therapy. Oncoimmunology, 3, Article ID: e28185. http://dx.doi.org/10.4161/onci.23803
Huang, Y., Goel, S., Duda, D.G., Fukumura, D. and Jain, R.K. (2013) Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy. Cancer Research, 73, 2943-2948. http://dx.doi.org/10.1158/0008-5472.CAN-12-4354
Jacobs, J.J., Snackey, C., Geldof, A.A., Characiejus, D., Van Moorselaar, R.J. and Den Otter, W. (2014) Inefficacy of Therapeutic Cancer Vaccines and Proposed Improvements. Casus of Prostate Cancer. Anticancer Research, 34, 2689-2700.
Mosser, D.M. and Edwards, J.P. (2008) Exploring the Full Spectrum of Macrophage Activation. Nature Reviews Immunology, 8, 958-969. http://dx.doi.org/10.1038/nri2448
Martinez, F.O. and Gordon, S. (2014) The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment. F1000Prime Reports, 6, 13. http://dx.doi.org/10.12703/P6-13
Barbul, A., Breslin, R.J., Woodyard, J.P., Wasserkrug, H.L. and Efron, G. (1989) The Effect of in Vivo T Helper and T Suppressor Lymphocyte Depletion on Wound Healing. Annals of Surgery, 209, 479-483. http://dx.doi.org/10.1097/00000658-198904000-00015
Erenpreiss, J. (1993) Current Concepts of Malignant Growth. Part A: From a Normal Cell to Cancer. Zvaigzne Publishers, Riga, 191 p.
Boyce, D.E., Jones, W.D., Ruge, F., Harding, K.G. and Moore, K. (2000) The Role of Lymphocytes in Human Dermal Wound Healing. British Journal of Dermatology, 143, 59-65. http://dx.doi.org/10.1046/j.1365-2133.2000.03591.x
Ishida, Y., Kondo, T., Takayasu, T., Iwakura, Y. and Mukaida, N. (2004) The Essential Involvement of Cross-Talk Between IFN-γ and TGF-β in the Skin Wound Healing Process. Journal of Immunology, 172, 1848-1855. http://dx.doi.org/10.4049/jimmunol.172.3.1848
Cao, Q., Wang, Y., Zheng, D., Sun, Y., Wang, Y., Lee, V.W., et al. (2010) IL-10/TGF-Beta-Modified Macrophages Induce Regulatory T Cells and Protect against Adriamycin Nephrosis. Journal of the American Society of Nephrology, 21, 933-942. http://dx.doi.org/10.1681/ASN.2009060592
Duffield, J.S. (2003) The Inflammatory Macrophage: A Story of Jekyll and Hyde. Clinical Science, 104, 27-38. http://dx.doi.org/10.1042/CS20020240
Eming, S.A., Krieg, T. and Davidson, J.M. (2007) Inflammation in Wound Repair: Molecular and Cellular Mechanisms. Journal of Investigative Dermatology, 127, 514-525. http://dx.doi.org/10.1038/sj.jid.5700701
Traversa, B. and Sussman, G. (2001) The Role of Growth Factors, Cytokines and Proteases in Wound Management. Primary Intention: The Australian Journal of Wound Management, 9, 161-167.
Gratchev, A., Schledzewski, K., Guillot, P. and Goerdt, S. (2001) Alternatively Activated Antigen-Presenting Cells: Molecular Repertoire, Immune Regulation, and Healing. Skin Pharmacology and Applied Skin Physiology, 14, 272-279. http://dx.doi.org/10.1159/000056357
Smith, C., Kruger, M.J., Smith, R.M. and Myburgh, K.H. (2008) The Inflammatory Response to Skeletal Muscle Injury: Illuminating Complexities. Sports Medicine, 38, 947-969. http://dx.doi.org/10.2165/00007256-200838110-00005
Lewis, C.J., Mardaryev, A.N., Sharov, A.A., Fessing, M.Y. and Botchkarev, V.A. (2014) The Epigenetic Regulation of Wound Healing. Advances in Wound Care (New Rochelle), 3, 468-475. http://dx.doi.org/10.1089/wound.2014.0522
Agaiby, A.D. and Dyson, M. (1999) Immuno-Inflammatory Cell Dynamics during Cutaneous Wound Healing. Journal of Anatomy, 195, 531-542. http://dx.doi.org/10.1046/j.1469-7580.1999.19540531.x
Gordon, S. and Martinez, F.O. (2010) Alternative Activation of Macrophages: Mechanism and Functions. Immunity, 32, 593-604. http://dx.doi.org/10.1016/j.immuni.2010.05.007
Lech, M., Grobmayr, R., Weidenbusch, M. and Anders, H-J. (2012) Tissues Use Resident Dendritic Cells and Macrophages to Maintain Homeostasis and to Regain Homeostasis upon Tissue Injury: The Immunoregulatory Role of Changing Tissue Environments. Mediators of Inflammation, 2012, Article ID: 951390. http://dx.doi.org/10.1155/2012/951390
Ghiringhelli, F., Ménard, C., Martin, F. and Zitvogel, L. (2006) The Role of Regulatory T Cells in the Control of Natural Killer Cells: Relevance during Tumor Progression. Immunological Reviews, 214, 229-238. http://dx.doi.org/10.1111/j.1600-065X.2006.00445.x
Radosavljevic, G.D., Jovanovic, I.P., Kanjevac, T.V. and Arsenijevic, N.N. (2013) The Role of Regulatory T Cells in the Modulation of Anti-Tumor Immune Response. Srpski arhiv za celokupno lekarstvo (Serbian), 141, 262-267. http://dx.doi.org/10.2298/SARH1304262R
Bruno, A., Ferlazzo, G., Albini, A. and Noonan, D.M. (2014) A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis. Journal of the National Cancer Institute, 106, dju200. http://www.ncbi.nlm.nih.gov/pubmed/25178695 http://dx.doi.org/10.1093/jnci/dju200
Sloan, E.K., Priceman, S.J., Cox, B.F., Yu, S., Pimentel, M.A., Tangkanangnukul, V., et al. (2010) The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer. Cancer Research, 70, 7042-7052. http://dx.doi.org/10.1158/0008-5472.CAN-10-0522
J?rgensen, A. (2013) Oxidatively Generated DNA/RNA Damage in Psychological Stress States. Danish Medical Journal, 60, Article ID: B4685. http://www.ncbi.nlm.nih.gov/pubmed/23809980
Aschbacher, K., O’Donovan, A., Wolkowitz, O.M., Dhabhar, F.S., Su, Y. and Epel, E. (2013) Good Stress, Bad Stress and Oxidative Stress: Insights from Anticipatory Cortisol Reactivity. Psychoneuroendocrinology, 38, 1698-1708. http://dx.doi.org/10.1016/j.psyneuen.2013.02.004
Flint, M.S. and Bovbjerg, D.H. (2012) DNA Damage as a Result of Psychological Stress: Implications for Breast Cancer. Breast Cancer Research, 14, 320. http://www.ncbi.nlm.nih.gov/pubmed/23490070 http://dx.doi.org/10.1186/bcr3189
Bukhtoyarov, O.V. and Samarin, D.M. (2009) Psychogenic Carcinogenesis: Carcinogenesis without Exogenic Carcinogens. Medical Hypotheses, 73, 531-536. http://dx.doi.org/10.1016/j.mehy.2009.06.004
Bartsch, H. and Nair, J. (2006) Chronic Inflammation and Oxidative Stress in the Genesis and Perpetuation of Cancer: Role of Lipid Peroxidation, DNA Damage, and Repair. Langenbeck’s Archives Surgery, 391, 499-510. http://dx.doi.org/10.1007/s00423-006-0073-1
Mantovani, A. (2010) Molecular Pathways Liking Inflammation and Cancer. Current Molecular Medicine, 10, 369-373. http://dx.doi.org/10.2174/156652410791316968
Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immunity, Inflammation, and Cancer. Cell, 140, 883-899. http://dx.doi.org/10.1016/j.cell.2010.01.025
Vaziri, H. and Benchimol, S. (1996) From Telomere Loss to p53 Induction and Activation of a DNA-Damage Pathway at Senescence: The Telomere Loss/DNA Damage Model of Cell Aging. Experimental Gerontology, 31, 295-301. http://dx.doi.org/10.1016/0531-5565(95)02025-X
Shimizu, I., Yoshida, Y., Suda, M. and Minamino, T. (2014) DNA Damage Response and Metabolic Disease. Cell Metabolism, 20, 967-977. http://dx.doi.org/10.1016/j.cmet.2014.10.008
Huang, J., Xie, Y., Sun, X., Zeh, H.J., Kang, R., Lotze, M.T. and Tang, D. (2014) DAMPs, Ageing, and Cancer: The “DAMP Hypothesis”. Ageing Research Reviews, 14, S1568-S1637. http://www.ncbi.nlm.nih.gov/pubmed/25446804 http://dx.doi.org/10.1016/j.arr.2014.10.004
Franceschi, C. and Campisi, J. (2014) Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 69, S4-S9. http://www.ncbi.nlm.nih.gov/pubmed/24833586 http://dx.doi.org/10.1093/gerona/glu057
Riggs, J.W., Barrilleaux, B.L., Varlakhanova, N., Bush, K.M., Chan, V. and Knoepfler, P.S. (2013) Induced Pluripotency and Oncogenic Transformation Are Related Processes. Stem Cells, 22, 37-50. http://dx.doi.org/10.1089/scd.2012.0375
Upadhyay, M., Samal, J., Kandpal, M., Singh, O.V. and Vivekanandan, P. (2013) The Warburg Effect: Insights from the Past Decade. Pharmacology & Therapeutics, 137, 318-330. http://dx.doi.org/10.1016/j.pharmthera.2012.11.003
Razungles, J., Cavaillès, V., Jalaguier, S. and Teyssier, C. (2013) The Warburg Effect: From Theory to Therapeutic Applications in Cancer. Médecine sciences (Paris), 29, 1026-1033. http://www.ncbi.nlm.nih.gov/pubmed/24280507 http://dx.doi.org/10.1051/medsci/20132911020
Ito, K. and Suda, T. (2014) Metabolic Requirements for the Maintenance of Self-Renewing Stem Cells. Nature Reviews Molecular Cell Biology, 15, 243-256. http://dx.doi.org/10.1038/nrm3772
Lee, K.E. and Simon, M.C. (2012) From Stem Cells to Cancer Stem Cells: HIF Takes the Stage. Current Opinion in Cell Biology, 24, 232-235. http://dx.doi.org/10.1016/j.ceb.2012.01.005
Natarajan, T.G., Ganesan, N. and Fitzgerald, K.T. (2010) Cancer Stem Cells and Markers: New Model of Tumorigenesis with Therapeutic Implications. Cancer Biomarkers, 9, 65-99.
Glenn, J.D. and Whartenby, K.A. (2014) Mesenchymal Stem Cells: Emerging Mechanisms of Immunomodulation and Therapy. World Journal of Stem Cells, 6, 526-539. http://dx.doi.org/10.4252/wjsc.v6.i5.526
Ivanovic, Z. (2009) Hypoxia or in Situ Normoxia: The Stem Cell Paradigm. Journal of Cellular Physiology, 219, 271-275. http://dx.doi.org/10.1002/jcp.21690
Riazi, A.M., Kwon, S.Y. and Stanford, W.L. (2009) Stem Cell Sources for Regenerative Medicine. Methods in Molecular Biology, 482, 55-90. http://dx.doi.org/10.1007/978-1-59745-060-7_5
Lane, S.W., Williams, D.A. and Watt, F.M. (2014) Modulating the Stem Cell Niche for Tissue Regeneration. Nature Biotechnology, 32, 795-803. http://dx.doi.org/10.1038/nbt.2978
Sell, S. (2004) Stem Cell Origin of Cancer and Differentiation Therapy. Critical Reviews in Oncology/Hematology, 51, 1-28. http://dx.doi.org/10.1016/j.critrevonc.2004.04.007
Koukourakis, M.I., Giatromanolaki, A., Bougioukas, G. and Sivridis, E. (2007) Lung Cancer: A Comparative Study of Metabolism Related Protein Expression in Cancer Cells and Tumor Associated Stroma. Cancer Biology and Therapy, 6, 1476-1479.
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A.K., Frank, P.G., et al. (2009) The Reverse Warburg Effect: Aerobic Glycolysis in Cancer Associated Fibroblasts and the Tumor Stroma. Cell Cycle, 8, 3984-4001. http://dx.doi.org/10.4161/cc.8.23.10238
Kasai, T., Chen, L., Mizutani, A., Kudoh, T., Murakami, H., Fu, L. and Seno, M. (2014) Cancer Stem Cells Converted from Pluripotent Stem Cells and the Cancerous Niche. Journal of Stem Cells and Regenerative Medicine, 10, 2-7.
Huggins, C. (1967) Endocrine-Induced Regression of Cancers. Science, 156, 1050-1054. http://dx.doi.org/10.1126/science.156.3778.1050
McCullough, K.D., Coleman, W.B., Smith, G.J. and Grisham, J.W. (1997) Age-Dependent Induction of Hepatic Tumor Regression by the Tissue Microenvironment after Transplantation of Neoplastically Transformed Rat Liver Epithelial Cells into the Liver. Cancer Research, 57, 1807-1813.
Maffini, M.V., Calabro, J.M., Soto, A.M. and Sonnenschein, C. (2005) Stromal Regulation of Neoplastic Development: Age-Dependent Normalization of Neoplastic Mammary Cells by Mammary Stroma. American Journal of Pathology, 167, 1405-1410. http://dx.doi.org/10.1016/S0002-9440(10)61227-8
Folkman, J. and Kalluri, R. (2004) Cancer without Disease. Nature, 427, 787. http://dx.doi.org/10.1038/427787a
Aguirre-Ghiso, J.A. (2007) Models, Mechanisms and Clinical Evidence for Cancer Dormancy. Nature Reviews Cancer, 7, 834-846. http://dx.doi.org/10.1038/nrc2256
Sosa, M.S., Bragado, P. and Aguirre-Ghiso, J.A. (2014) Mechanisms of Disseminated Cancer Cell Dormancy: An Awakening Field. Nature Reviews Cancer, 14, 611-622. http://dx.doi.org/10.1038/nrc3793
Manjili, M.H. (2014) The Inherent Premise of Immunotherapy for Cancer Dormancy. Cancer Research, 74, 1-5. http://dx.doi.org/10.1158/0008-5472.CAN-14-2440
Chambers, A.F., Groom, A.C. and MacDonald, I.C. (2002) Dissemination and Growth of Cancer Cells in Metastatic Sites. Nature Reviews Cancer, 2, 563-572. http://dx.doi.org/10.1038/nrc865
Mehlen, P. and Puisieux, A. (2006) Metastasis: A Question of Life or Death. Nature Reviews Cancer, 6, 449-458. http://dx.doi.org/10.1038/nrc1886
Luzzi, K.J., MacDonald, I.C., Schmidt, E.E., Kerkvliet, N., Morris, V.L., Chambers, A.F. and Groom, A.C. (1998) Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early Micrometastases. American Journal of Pathology, 153, 865-873. http://dx.doi.org/10.1016/S0002-9440(10)65628-3
Kleffel, S. and Schatton, T. (2013) Tumor Dormancy and Cancer Stem Cells: Two Sides of the Same Coin? Advances in Experimental Medicine and Biology, 734, 145-179. http://dx.doi.org/10.1007/978-1-4614-1445-2_8
El Saghir, N.S., Elhajj, I.I., Geara, F.B. and Hourani, M.H. (2005) Trauma-Associated Growth of Suspected Dormant Micrometastasis. BMC Cancer, 5, 94. http://dx.doi.org/10.1186/1471-2407-5-94
Demicheli, R., Retsky, M.W., Hrushesky, W.J. and Baum, M. (2007) Tumor Dormancy and Surgery-Driven Interruption of Dormancy in Breast Cancer: Learning from Failures. Nature Clinical Practice Oncology, 4, 699-710. http://dx.doi.org/10.1038/ncponc0999
Mocellin, S. and Nitti, D. (2008) Therapeutics Targeting Tumor Immune Escape: Towards the Development of New Generation Anticancer Vaccines. Medicinal Research Reviews, 28, 413-444. http://dx.doi.org/10.1002/med.20110
Mittal, D., Gubin, M.M., Schreiber, R.D. and Smyth, M.J. (2014) New Insights into Cancer Immunoediting and Its Three Component Phases—Elimination, Equilibrium and Escape. Current Opinion in Immunology, 27, 16-25. http://dx.doi.org/10.1016/j.coi.2014.01.004
Corthay, A. (2014) Does the Immune System Naturally Protect Against Cancer? Frontiers in Immunology, 5, 197. http://dx.doi.org/10.3389/fimmu.2014.00197
Gajewski, T.F., Woo, S.R., Zha, Y., Spaapen, R., Zheng, Y., Corrales, L. and Spranger, S. (2013) Cancer Immunotherapy Strategies Based on Overcoming Barriers within the Tumor Microenvironment. Current Opinion in Immunology, 25, 268-276. http://dx.doi.org/10.1016/j.coi.2013.02.009
Yi, D.H. and Appel, S. (2013) Current Status and Future Perspectives of Dendritic Cell-Based Cancer Immunotherapy. Scandinavian Journal of Immunology, 78, 167-171. http://dx.doi.org/10.1111/sji.12060
Mougiakakos, D., Choudhury, A., Lladser, A., Kiessling, R. and Johansson, C.C. (2010) Regulatory T Cells in Cancer. Advances in Cancer Research, 107, 57-117. http://dx.doi.org/10.1016/S0065-230X(10)07003-X
Oleinika, K., Nibbs, R.J., Graham, G.J. and Fraser, A.R. (2013) Suppression, Subversion and Escape: The Role of Regulatory T Cells in Cancer Progression. Clinical and Experimental Immunology, 171, 36-45. http://dx.doi.org/10.1111/j.1365-2249.2012.04657.x
López, M., Aguilera, R., Pérez, C., Mendoza-Naranjo, A., Pereda, C., Ramirez, M., et al. (2006) The Role of Regulatory T Lymphocytes in the Induced Immune Response Mediated by Biological Vaccines. Immunobiology, 211, 127-136. http://dx.doi.org/10.1016/j.imbio.2005.11.003
Song, S., Zhang, K., You, H., Wang, J., Wang, Z., Yan, C. and Liu, F. (2010) Significant Anti-Tumour Activity of Adoptively Transferred T Cells Elicited by Intratumoral Dendritic Cell Vaccine Injection through Enhancing the Ratio of CD8+ T Cell/Regulatory T Cells in Tumour. Clinical and Experimantal Immunology, 162, 75-83. http://dx.doi.org/10.1111/j.1365-2249.2010.04226.x
Parmiani, G., Pilla, L., Maccalli, C. and Russo, V. (2011) Autologous versus Allogeneic Cell-Based Vaccines? Cancer Journal, 17, 331-336. http://dx.doi.org/10.1097/PPO.0b013e3182337a76
Fujiwara, S., Wada, H., Miyata, H., Kawada, J., Kawabata, R., Nishikawa, H., et al. (2012) Clinical Trial of the Intratumoral Administration of Labeled DC Combined with Systemic Chemotherapy for Esophageal Cancer. Journal of Immunotherapy, 35, 513-521. http://dx.doi.org/10.1097/CJI.0b013e3182619cb4
Longley, D.B. and Johnston, P.G. (2005) Molecular Mechanisms of Drug Resistance. Journal of Pathology, 205, 275-292. http://dx.doi.org/10.1002/path.1706
Rebucci, M. and Michiels, C. (2013) Molecular Aspects of Cancer Cell Resistance to Chemotherapy. Biochemical Pharmacology, 85, 1219-1226. http://dx.doi.org/10.1016/j.bcp.2013.02.017
Salehan, M.R. and Morse, H.R. (2013) DNA Damage Repair and Tolerance: A Role in Chemotherapeutic Drug Resistance. British Journal of Biomedical Science, 70, 31-40.
Sebens, S. and Schafer, H. (2012) The Tumor Stroma as Mediator of Drug Resistance—A Potential Target to Improve Cancer Therapy? Current Pharmaceutical Biotechnology, 13, 2259-2272. http://dx.doi.org/10.2174/138920112802501999
Gordon, R.R. and Nelson, P.S. (2012) Cellular Senescence and Cancer Chemotherapy Resistance. Drug Resistance Updates, 15, 123-131. http://dx.doi.org/10.1016/j.drup.2012.01.002
Wang, Z. and Chen, W. (2013) Emerging Roles of SIRT1 in Cancer Drug Resistance. Genes and Cancer, 4, 82-90. http://dx.doi.org/10.1177/1947601912473826
Ravindran Menon, D., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., et al. (2014) A Stress-Induced Early Innate Response Causes Multidrug Tolerance in Melanoma. Oncogene, Published Online. http://www.ncbi.nlm.nih.gov/pubmed/25417704
Li, S., Kennedy, M., Payne, S., Kennedy, K., Seewaldt, V.L., Pizzo, S.V. and Bachelder, R.E. (2014) Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy. PLoS ONE, 9, e98021. http://dx.doi.org/10.1371/journal.pone.0098021
Naito, M., Aisu, N., Maki, K., Nakagawa, M., Yoshida, Y., Hoshino, S. and Yamashita, Y. (2014) A Case of Unresected Gastric Cancer That Maintained Long Tumor Dormancy by Use of Paclitaxel+S-1 Combination Therapy. Gan to Kagaku Ryoho, 41, 241-244.
Mitchell, T. and Turton, P. (2011) “Chemobrain”: Concentration and Memory Effects in People Receiving Chemotherapy—A Descriptive Phenomenological Study. European Journal of Cancer Care, 20, 539-548. http://dx.doi.org/10.1111/j.1365-2354.2011.01244.x
Areti, A., Yerra, V.G., Naidu, V. and Kumar, A. (2014) Oxidative Stress and Nerve Damage: Role in Chemotherapy Induced Peripheral Neuropathy. Redox Biology, 2, 289-295. http://dx.doi.org/10.1016/j.redox.2014.01.006
Anderson, B. and Sawyer, D.B. (2008) Predicting and Preventing the Cardiotoxicity of Cancer Therapy. Expert Review of Cardiovascular Therapy, 6, 1023-1033. http://dx.doi.org/10.1586/14779072.6.7.1023
Abid, S.H., Malhotra, V. and Perry, M.C. (2001) Radiation-Induced and Chemotherapy-Induced Pulmonary Injury. Current Opinion in Oncology, 13, 242-248. http://dx.doi.org/10.1097/00001622-200107000-00006
Andreyev, H.J. (2010) A Physiological Approach to Modernize the Management of Cancer Chemotherapy-Induced Gastrointestinal Toxicity. Current Opinion in Supportive and Palliative Care, 4, 19-25. http://dx.doi.org/10.1097/SPC.0b013e32833575cc
Al-Tweigeri, T., Nabholtz, J.M. and Mackey, J.R. (1996) Ocular Toxicity and Cancer Chemotherapy: A Review. Cancer, 78, 1359-1373. http://dx.doi.org/10.1002/(SICI)1097-0142(19961001)78:7 3.0.CO;2-G
Kalialis, L.V., Drzewiecki, K.T. and Klyver, H. (2009) Spontaneous Regression of Metastases from Melanoma: Review of the Literature. Melanoma Research, 19, 275-282. http://dx.doi.org/10.1097/CMR.0b013e32832eabd5
Jessy, T. (2011) Immunity over Inability: The Spontaneous Regression of Cancer. Journal of Natural Science, Biology and Medicine, 2, 43-49. http://dx.doi.org/10.4103/0976-9668.82318
Papac, R.J. (1998) Spontaneous Regression of Cancer: Possible Mechanisms. In Vivo, 12, 571-578.
Lagova, N.D. (1978) Mechanism of Mammary Cancer Regression in Lactating Rats. Biulleten Eksperimentalnoi Biologii I Meditsiny (Moskva), 85, 582-585.
Buijs, M., Geschwind, J.F., Syed, L.H., Ganapathy-Kanniappan, S., Kunjithapatham, R., Wijlemans, J.W., et al. (2012) Spontaneous Tumor Regression in a Syngeneic Rat Model of Liver Cancer: Implications for Survival Studies. Journal of Vascular and Interventional Radiology, 23, 1685-1691. http://dx.doi.org/10.1016/j.jvir.2012.08.025
Chang, W.Y. (2000) Complete Spontaneous Regression of Cancer: Four Case Reports, Review of Literature, and Discussion of Possible Mechanisms Involved. Hawaii Medical Journal, 59, 379-387.
Bukhtoyarov, O.V. and Samarin, D.M. (2012) Psychogenic Carcinogenesis. In: Mohan, R., Ed., Advances in Cancer Management, InTech, Rijeka, 17-56.
Moser, R.P., Arndt, J., Han, P.K., Waters, E.A., Amsellem, M. and Hesse, B.W. (2014) Perceptions of Cancer as a Death Sentence: Prevalence and Consequences. Journal of Health Psychology, 19, 1518-1524. http://dx.doi.org/10.1177/1359105313494924
Bukhtoyarov, O.V. and Samarin, D.M. (2013) Psychogenic Activation Phenomenon of Specific Anti-Tumor Immunity in Cancer Patients. International Journal of Medicine and Medical Sciences, 5, 198-205.
Ikemi, Y., Nakagawa, S., Nagakawa, T. and Sugita, M. (1975) Psychosomatic Consideration on Cancer Patients Who Have Made a Narrow Escape from Death. Dynamic Psychiatry, 8, 77-91.
Niakan, B. (1998) A Mechanism of the Spontaneous Remission and Regression of Cancer. Cancer Biotherapy and Radiopharmaceuticals, 13, 209-210. http://dx.doi.org/10.1089/cbr.1998.13.209
MаcAdam, D. (2003) Spontaneous Regression: Cancer and the Immune System. Replica Books, New York, 164 p.
Zhong, H., Han, B., Tourkova, I.L., Lokshin, A., Rosenbloom, A., Shurin, M.R. and Shurin, G.V. (2007) Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth. Clinical Cancer Research, 13, 5455-5462. http://dx.doi.org/10.1158/1078-0432.CCR-07-0517
Bukhtoyarov, O.V. and Samarin, D.M. (2013) Psycho-Immunological Rehabilitation of Advanced Cancer Patients with Psychogenic Medical History. Journal of Medicine and Medical Sciences, 5, 489-502.